Nurix Therapeutics (NRIX) Earnings Date, Estimates & Call Transcripts $12.44 -0.23 (-1.82%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$12.54 +0.10 (+0.80%) As of 07/11/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nurix Therapeutics Earnings Summary Nurix Therapeutics released Q2 2025 earnings on July 9, 2025, reporting an EPS of -$0.52, which topped the consensus estimate of -$0.79 by $0.27. Quarterly revenue was reported to be $44,056 billion, above analysts' expectations of $16.26 million. With a trailing EPS of -$2.61, Nurix Therapeutics' earnings are expected to decrease next year, from ($2.99) to ($3.01) per share. Latest Q2 Earnings DateJul. 9EstimatedConsensus EPS (Jul. 9) -$0.79 Actual EPS (Jul. 9) -$0.52 Beat By $0.27 Actual Revenue (Jul. 9) $44,056.00BQ2 2025 Earnings ResourcesQ2 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Nurix Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nurix Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNRIX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRIX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Nurix Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.89-$0.60-$0.75Q2 20252-$0.84-$0.62-$0.73Q3 20252-$0.96-$0.76-$0.86Q4 20252-$0.99-$0.78-$0.89 FY 2025 8 -$3.68 -$2.76 -$3.22 Q1 20262-$1.03-$0.80-$0.92Q2 20262-$1.09-$0.82-$0.96Q3 20262-$1.15-$0.84-$1.00Q4 20262-$1.01-$0.87-$0.94 Nurix Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/9/2025Q2 2025-$0.79-$0.52+$0.27-$0.52$16.26M$44,056.00B4/8/2025Q1 2025-$0.72-$0.67+$0.05-$0.67$12.78M$18.45M1/28/2025Q4 2024-$0.67-$0.75 -$0.08-$0.75--10/11/2024--$0.67-$0.67--$0.67$13.85M$12.59M7/11/2024Q2 2024-$0.63-$0.71 -$0.08-$0.71$19.35M$12.09M4/10/2024Q1 2024-$0.80-$0.76+$0.04-$0.76$14.58M$16.59M2/15/2024Q4 2023-$0.51-$0.77 -$0.26-$0.77$30.66M$15.16M10/12/2023Q3 2023-$0.84-$0.68+$0.16-$0.68$19.98M$18.47M7/13/2023Q2 2023-$0.57-$0.45+$0.12-$0.45$21.96M$30.68M Nurix Therapeutics Earnings - Frequently Asked Questions When did Nurix Therapeutics announce their last quarterly earnings? Nurix Therapeutics (NASDAQ:NRIX) last announced its quarterly earning data on Wednesday, July 9, 2025. Learn more on NRIX's earnings history. Did Nurix Therapeutics beat their earnings estimates last quarter? In the previous quarter, Nurix Therapeutics (NASDAQ:NRIX) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.27. Learn more on analysts' earnings estimate vs. NRIX's actual earnings. How much revenue does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded annual revenue of $88.38 million. How much profit does Nurix Therapeutics generate each year? Nurix Therapeutics (NASDAQ:NRIX) has a recorded net income of -$193.57 million. NRIX has generated -$2.61 earnings per share over the last four quarters. What is Nurix Therapeutics' EPS forecast for next year? Nurix Therapeutics' earnings are expected to decrease from ($2.99) per share to ($3.01) per share in the next year. More Earnings Resources from MarketBeat Related Companies Ultragenyx Pharmaceutical Earnings Date Merus Earnings Date Arcellx Earnings Date SpringWorks Therapeutics Earnings Date Avidity Biosciences Earnings Date ACADIA Pharmaceuticals Earnings Date Scholar Rock Earnings Date Viking Therapeutics Earnings Date Protagonist Therapeutics Earnings Date MoonLake Immunotherapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s Next This page (NASDAQ:NRIX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRIX Stock Alerts